about
A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumoniaThe index case for the fungal meningitis outbreak in the United States.ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung diseaseExtensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.Rare variants in RTEL1 are associated with familial interstitial pneumoniaRight place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosisGenetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis.School-based obesity prevention programs: an evidence-based review.Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.Accumulation of isolevuglandin-modified protein in normal and fibrotic lung.Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.The genetic basis of idiopathic pulmonary fibrosisDisruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunctionTelomeres revisited: RTEL1 variants in pulmonary fibrosis.Personalizing Therapy in Idiopathic Pulmonary Fibrosis: A Glimpse of the Future?A Phenome-Wide Association Study Identifies a Novel Asthma Risk Locus Near TERC.Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).Endoplasmic reticulum stress in the pathogenesis of fibrotic disease.Three-dimensional spatial analysis of missense variants in RTEL1 identifies pathogenic variants in patients with Familial Interstitial Pneumonia.A Shared Pattern of β-catenin Activation in Bronchopulmonary Dysplasia and Idiopathic Pulmonary Fibrosis.Utility of Flexible Bronchoscopic Cryobiopsy for Diagnosis of Diffuse Parenchymal Lung Diseases.Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families.Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis.Reply: The Genetic Diagnosis of Interstitial Lung Disease: A Need for an International Consensus.Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.Interstitial Pneumonia with Autoimmune Features: An emerging challenge at the intersection of rheumatology and pulmonologyLocalized hypoxia links ER stress to lung fibrosis through induction of C/EBP homologous proteinPD-1 up-regulation on CD4 T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 productionSurvival implications of transbronchial cryobiopsy and other diagnostic modalities in idiopathic pulmonary fibrosisSuccessful Establishment of Primary Type II Alveolar Epithelium with 3D Organotypic CocultureAnalysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyDevelopment and Progression of Radiologic Abnormalities in Individuals at Risk for Familial ILDEpithelial Injury and Dysfunction in the Pathogenesis of Idiopathic PulmonaryFibrosisMUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosisCurrent Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research StatementProgress in Understanding and Treating Idiopathic Pulmonary FibrosisResequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
P50
Q28307444-65152B2C-5E71-460B-9BA9-A6600B463936Q34307185-5971DC71-ABB1-45BB-82E1-1DF2F765E24BQ34354002-6312BF81-DB97-40CC-B6DC-3B39640E7C08Q35050337-B6519EC8-A9DA-4F17-B97F-1AD46564E32FQ35153490-A3CC601D-7BE4-401B-B058-1662B5D09C35Q35262015-36AAF4E0-F907-419C-87EE-C97A4E429845Q35850237-8901C76A-FC3B-4DC9-B2FE-FE8FE846BA7AQ36485998-709D3763-885F-4148-B738-636F0BFDAD3FQ37115411-AFA469B3-E3AF-432F-A534-534E6B9FC626Q37277715-97CF7000-31E3-4B0A-8780-CE026B057130Q37474995-B9227AD6-6050-4CA3-84D9-A5ABAB9251CCQ37555367-DA27F352-0348-4583-9C55-6A1E2098E298Q38448103-B043BB12-F400-4735-933E-74DF661089CEQ38450447-1CAAC35A-D66D-4AEB-864E-5CFD12133BCDQ40777090-69896B06-F330-440D-B2C1-03903E4AF913Q41763904-767FEBBF-ACD8-4F2A-B41B-C99CD960AFF9Q42378740-0D3C9DE9-39B7-4BF1-A04D-E9528297C912Q43062778-B2368127-2523-4B65-A3A1-26C691435837Q43062900-A23602BC-D6E0-4977-B6D8-B0503D452EE8Q47117383-640E6F01-D368-4A57-B36A-A31B95CAEFBCQ47239353-B03DDB5C-2A49-4C5D-9E22-CF0506BB5F71Q47557378-1502104B-2A5A-44FF-95DE-BFB783BCB8B7Q47650422-95ABF1A1-02D7-4930-8BFE-3CDCF1192C84Q47801312-76DA0059-50C6-4875-99E4-47E5D767C887Q47914471-2754DE70-0810-4C08-8C91-233267A67EB2Q48037972-991638D6-517E-4871-9372-B5090D9169BEQ48640841-12CB0BF0-C61D-40D4-8BEC-1D87A914A4A4Q52721106-76B37BCA-B3AC-4489-9D48-F7DF6C0B4AF2Q57174251-4DF8318B-41EF-4CE8-89AD-55647312F3A4Q58710836-CA54FC82-6AF0-4A67-9342-9AAB81219057Q63363261-CD0DF1D0-F0DF-456D-B944-16CD78FFB94DQ64248951-D7C6D5A7-60E2-4E1D-BB85-28A47A178B78Q88292735-6B2739D8-FBED-4AD8-B4EC-20E0AC1BA52DQ89067942-CECF68B6-1FFF-4BCF-9FCF-3B93F5636C31Q89503712-96C64EE6-4BAE-460C-BEF6-1925643FFF83Q90210167-675DE3CE-7616-472D-9D47-ED029B774DFCQ90316654-1B8BE58B-35BF-4F18-89A2-BE178E67E53FQ91034846-6CD09AE3-C45F-4952-9EDD-78B17D7BE015Q91255542-670AAB1F-B331-4B7E-B721-8A951FD3C0DDQ91601659-258AA279-46EA-4F01-9963-474C95D2FF5F
P50
description
physician and biomedical researcher
@en
wetenschapper
@nl
name
Jonathan Andrew Kropski
@en
Jonathan Andrew Kropski
@es
Jonathan Andrew Kropski
@nl
type
label
Jonathan Andrew Kropski
@en
Jonathan Andrew Kropski
@es
Jonathan Andrew Kropski
@nl
altLabel
Jonathan A Kropski
@en
Jonathan Kropski
@en
prefLabel
Jonathan Andrew Kropski
@en
Jonathan Andrew Kropski
@es
Jonathan Andrew Kropski
@nl
P101
P21
P31
P496
0000-0002-8923-1344